Results of bird flu vaccine

The Influenza virus.

Tapas dinner for participants. Foto: Kristian Jensen

The vaccination itself was conducted in March- May (see here for more information). Following this, the Influenza Centre has studied the kinetics and results of the vaccination through frequent blood samples collected from the vaccinees. Our scientists have then used this information to analyze the immune response of the people vaccinated in order to get an indication as to how long the immunity lasts. No serious side-averse events occurred during the trial. The most frequent side-effect was a local mild and transient soreness at the injection site, although one fifth of all the people vaccinated experience no side-effects at all.

The vaccine itself induced good antibodiy and immune cell (B and T) responses, and the new adjuvant strengthened resistance to bird flu. The trial has thus help create a solid foundation for further research and improvements on vaccines against the H5N1-virus.

The positive research results were celebrated with a tapas dinner where all the volunteering participants were invited.

The scientists at the Influenza Centre.